Gareev, Ilgiz,
Aamir, Ahmad,
Jiaqi, Wang,
Aferin, Beilerli,
Tatiana, Ilyasova,
Albert, Sufianov,
Ozal, Beylerli (2023) RNAs),
long non-coding RNAs
(lncRNAs), and circular RNAs (circRNAs). They are involved in a wide
rangeGareev, Ilgiz,
Kudriashov, Valentin,
Sufianov, Albert,
Begliarzade, Sema,
Ilyasova, Tatiana,
Liang, Yanchaof,
Beylerli, Ozal (2022) The role of
long non-coding RNA ANRIL in the development of atherosclerosis
Beylerli, Ozal,
Ju, Jiaming,
Beilerli, Aferin,
Gareev, Ilgiz,
Shumadalova, Alina,
Ilyasova, Tatiana,
Bai, Yunlong,
Yang, Baofeng (2023) findings are prerequisites for improving the treatment of AF and the associated cardiac conditions.
LongGareev, Ilgiz,
Encarnacion Ramirez, Manuel de Jesus,
Nurmukhametov, Renat,
Ivliev, Denis,
Shumadalova, Alina,
Ilyasova, Tatiana,
Beilerli, Aferin,
Wang, Chunlei (2023) biomarkers and therapeutic targets specifically tailored for glioma. In recent years,
long non-coding RNAs
Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) , and it has been found that lncRNAs (
long non-coding RNA) play a key role in angiogenesis, tumor growth
RNAs) and
long non-coding RNAs (lncRNAs), as key regulators in the pathogenesis of hypertension. These nc
Lu, Enzhou,
Gareev, Ilgiz,
Yuan, Chao,
Liang, Yanchao,
Sun, Jingxian,
Chen, Xin,
Beylerli, Ozal,
Sufianov, Albert,
Zhao, Shiguang,
Yang, Guang (2022) influenced by non-coding RNAs, particularly, by microRNAs (miRNAs) and
long non-coding RNAs (lncRNAs). mi
Wu, Hongjie,
Beylerli, Ozal,
Gareev, Ilgiz,
Beilerli, Aferin,
Ilyasova, Tatiana,
Talybov, Rustam,
Sufianov, Albert,
Guo, Xiaolong (2023) verification between May 2019 and October 2022.
Depending on the histological conclusion, two study groups